A Study of Duloxetine in Fibromyalgia

PHASE3CompletedINTERVENTIONAL
Enrollment

393

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Fibromyalgia
Interventions
DRUG

Duloxetine 60 mg

Duloxetine 60 mg taken orally once every day for 15 weeks

DRUG

Placebo

Placebo taken orally once every day for 15 weeks

Trial Locations (1)

982-0032

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Miyagi

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Shionogi

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY

NCT01552057 - A Study of Duloxetine in Fibromyalgia | Biotech Hunter | Biotech Hunter